Showing 5,803 results

Filters Content type: News, Editors' picks Topic: HIV treatment

Treatment is recommended for all people living with HIV. It involves taking a combination of antiretroviral drugs. This stops the virus from replicating and allows the immune system to strengthen and fight infections.

Injectable & long-acting HIV treatment

ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment

Editor's pick
ViiV Healthcare press release
22 January 2021
The search for an HIV prevention vaccine

We Found A COVID-19 Vaccine In Months. What About One For HIV?

Editor's pick
HuffPost
21 January 2021
Confidentiality, consent & medical ethics

Molecular HIV surveillance: friend or foe?

News
18 January 2021
People & personal stories

Anthony Fauci: “I don’t do this because I’m a hero. I do it because it’s necessary.”

News
14 January 2021
Bad science & bogus treatments

Fact check: SARS-CoV-2 was not created using genes from HIV, Fauci does not hold patents for an 'HIV component' to SARS-CoV-2

Editor's pick
Reuters
8 January 2021
Side effects

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

News
5 January 2021
Bad science & bogus treatments

Fact check: No evidence SARS-CoV-2 is a HIV-based bioweapon; trials show vaccines against the virus are effective

Editor's pick
Reuters
3 January 2021
Injectable & long-acting HIV treatment

ViiV Healthcare announces the Marketing Authorisation of the first complete long-acting injectable HIV treatment in Europe

Editor's pick
ViiV Healthcare press release
21 December 2020
Access to healthcare

Malta HIV patients forced to crowdsource medicine

Editor's pick
Deutsche Welle
17 December 2020
The search for an HIV prevention vaccine

Facebook posts make misleading comparison about research into Covid-19, HIV, cancer and common cold

Editor's pick
AFP Factcheck
16 December 2020
Resistance

People with NNRTI resistance have poorer responses to dolutegravir, South African study finds

News
14 December 2020
New & experimental HIV treatments

ViiV Healthcare announces positive CHMP opinion for Rukobia (fostemsavir), a first-in-class attachment inhibitor for the treatment of adults with multidrug-resistant HIV with few treatment options available

Editor's pick
ViiV Healthcare press release
11 December 2020
Weight gain & lipodystrophy

More weight gain in people starting HIV treatment with newer integrase inhibitors or darunavir

News
11 December 2020
Treatment outcomes & life expectancy

WHO reveals leading causes of death and disability worldwide: 2000-2019

Editor's pick
World Health Organization
10 December 2020
Treatment outcomes & life expectancy

Hospitalization Rates Have Declined Among People With HIV

Editor's pick
POZ
10 December 2020
PrEP programmes & uptake

Voucher scheme to encourage young South African women to take PrEP has modest impact

Editor's pick
Avert
10 December 2020
HIV treatment

Top 10 HIV Clinical Developments of 2020

Editor's pick
TheBodyPro
1 December 2020
Retention & linkage to care

South Africa: ‘Welcome Back Service’ aims to help people get back on HIV treatment

Editor's pick
Spotlight
1 December 2020
Drug interactions & pharmacokinetics

Can HIV Meds Interact With COVID-19 Treatment? Here's What We Know

Editor's pick
TheBody
25 November 2020
Treatment outcomes & life expectancy

US: HIV-Related Deaths Decline, but Disparities Still Exist Among Multiple Populations

Editor's pick
American Journal of Managed Care
24 November 2020
Ethnic & cultural minorities

UK: Black people less likely to be engaged in HIV care, with more cases of viral rebound

News
23 November 2020
Tuberculosis & HIV

TB policies aren't working. Here's why.

Editor's pick
Devex
20 November 2020
New & experimental HIV treatments

Data sets up 2021 filings for Gilead's twice-a-year HIV drug lenacapavir

Editor's pick
Pharmaphorum
20 November 2020
Injectable & long-acting HIV treatment

A Long-Lasting, More Effective HIV Drug Is A Psychological Relief For Patients

Editor's pick
NPR
20 November 2020